openPR Logo
Press release

Four Interactive Sessions to Take Place at the 2019 Respiratory Drug Delivery Conference

10-09-2019 05:38 PM CET | Health & Medicine

Press release from: SMi Group

Respiratory Drug Delivery Conference

Respiratory Drug Delivery Conference

SMi Reports: Four interactive sessions will take place at the inaugural Respiratory Drug Delivery conference to be held on the 6th December in London.

SMi is pleased to provide attendees with the opportunity to take part in over five hours of interactive sessions as part of the two-day conference. The interactive sessions will focus on novel routes of drug distribution and long-term solutions to dealing with the needs of patients.
The inaugural conference is part of SMi’s newly branded Asthma and COPD series and will bring together clinical researchers, respiratory drug manufacturers and solution providers to present and discuss the latest developments in respiratory drug delivery.

More details can be found here:

Interactive Session 1: “Novel Approaches to characterise Aerosol Dynamics”

Key topics:
• Introductory overview and case studies highlighting the reality of different characterisation approaches
• Assessing Drug Delivery methods, discussing mechanisms and dynamic breakup
• Reviewing the effects of the lung environment, including heat and relative humidity and why do dynamics matter in drug delivery?

Dr David Lewis, Aerosil Science Director Drug Delivery Technologies, Chiesi

Interactive Session 2: “Digital Enablement: could remote photoplethysmograpy be key to patient monitoring compliance?”

Key topics:

• Assessing the ability for remote photoplethysmographic (rPPG) technologies to solve the challenges of compliance in patient self-monitoring
• Reviewing the value of such technologies in predicting and preventing respiratory exacerbations
• Considering the barriers to adoption of mass rPPG monitoring

Laurence Pearce, Founder and CEO, Xim Ltd.

Interactive Session 3: “Respiratory drug delivery: what may the future hold?”

Key Topics:
• Setting the scene for how intelligent drug delivery can transform the field of respiration and assessing the emerging technologies landscape for improved respiratory drug delivery
• Discussion on benefits and challenges of nasal route for drug administration
Mayur Patel, Leading innovative medical and combination product development, PA Consulting

Interactive Session 4: Device Discovery: How relevant is a device to the patient

Key topics:
• Introduction to device discovery
• Open discussion on real world studies and feedback on hurdles
• Reviewing the operational challenges of RWS
• Assessing what the data challenges are once a study is up and running
Abid Raza, Respiratory Medicine, Independent Medical Expert

Registrations for the conference can be made online at Register by the 31st October to save £100 off the conference price.

Respiratory Drug Delivery
5th – 6th December 2019
Copthorne Tara Hotel, London, UK

For delegate enquiries please contact Hakam Panum on +44 (0) 20 7827 6128 or

For sponsorship enquiries please contact Alia Malick on +44 (0) 207 827 6168 or

India House, 45 Curlew Street, London, SE1 2ND

About SMi Group: Established since 1993, the SMi Group is a global event-production company that specializes in Business-to-Business Conferences, Workshops, Masterclasses and online Communities. We create and deliver events in the Defence, Security, Energy, Utilities, Finance and Pharmaceutical industries. We pride ourselves on having access to the world’s most forward-thinking opinion leaders and visionaries, allowing us to bring our communities together to Learn, Engage, Share and Network. More information can be found at

This release was published on openPR.

Permanent link to this press release:

Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Four Interactive Sessions to Take Place at the 2019 Respiratory Drug Delivery Conference here

News-ID: 1845571 • Views: 191

More Releases from SMi Group

Pharma Microbiology UK Conference to discuss Environmental Monitoring
SMi Reports: The Pharmaceutical Microbiology UK conference, taking place on 20 and 21 January 2020 in London, will include a variety of innovative presentations from the environmental monitoring field. With the slowdown in world economic growth, the Pharmaceutical & Biotechnology Environmental Monitoring industry has suffered a certain impact. However, it has still maintained a relatively optimistic growth over the past four years, as the market size maintained an annual growth rate
Exclusive platform updates on the ASCOD, AJAX, Challenger 2, Warrior IFV, PATRIA …
SMi Reports: Senior experts to present exclusive communication and systems updates at the Future Armoured Vehicles Situational Conference in London, next April SMi Group’s 5th Annual Future Armoured Vehicles Situational Awareness will commence on the 1st and 2nd April 2020, in London. The conference will delve deeper into the role of industry, inviting technical leads, platform managers and programme directors to share their insights on the latest systems and sub-systems, providing
Registration Opens for Future Armoured Vehicles Situational Awareness 2020 in Lo …
SMi reports: The agenda has been released for the upcoming Future Armoured Vehicles Situational Awareness Conference, taking place in London in April 2020. In an increasingly complex and congested digital battlespace, the need to provide near real-time information on the whereabouts of an adversary’s location and intent, using enhanced situational awareness capabilities, is vital in aiding armoured units to respond quickly to incoming threats. It is therefore imperative for defence forces
Registration opens for Smart Water Systems Conference 2020
SMi Reports: Registration now available for SMi’s 9th Annual Smart Water Systems, in London. SMi Group is proud to announce the 9th Annual Smart Water Systems Conference which will take place on 20th – 21st April 2020, in London, UK. The two-day event will offer updates on current projects through case studies from water utility companies such as Anglian Water, De Watergroep, SES Water, DWR Cymru Welsh Water, Thames Water and

All 5 Releases

More Releases for Respiratory

Global Respiratory Protection Equipment Market Research Report
This report studies the global Respiratory Protection Equipment market status and forecast, categorizes the global Respiratory Protection Equipment market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in North America, Europe, Japan, China, and other regions (India, Southeast Asia). The major manufacturers covered in this report 3M Avon Protection Systems Bullard Group Honeywell International MSA Safety Alpha Pro Tech Ansell
Respiratory Inhalers Market - Global Industry Analysis 2025
Chronic respiratory diseases are the group of chronic diseases which affect airways, lungs and the other parts of respiratory system. Chronic respiratory disease include asthma and respiratory allergies, Chronic Obstructive Pulmonary Disease (COPD), Occupational Lung Diseases, Sleep Apnoea Syndrome and Pulmonary Hypertension. However 70% chronic respiratory disease are asthma and chronic obstructive pulmonary disease. In 2012, globally, 1 billion people are affected with chronic respiratory disease and account for 7%
Respiratory Monitoring Devices Industry Trends
Global Respiratory Monitoring Devices Market: Snapshot Factors at the forefront of driving the demand in the global respiratory monitoring devices market are the rising number of cigarette smokers and a worsening air quality on account of rampant pollution. Further, a burgeoning geriatric population highly susceptible to lung diseases has also pushed up the demand in the market. Countering its growth, however, are the steep prices of newer, sophisticated respiratory monitoring devices,
Respiratory Monitoring Devices Market 2015
While a handful players have taken up a majority share in the global distribution of respiratory monitoring devices, the remainder of the market is marked by a very large number of small players. Of the key multinationals dominating the distribution of respiratory monitoring devices in 2014, CareFusion Corporation, Smiths Medical, and ResMed, Inc., had garnered a total share of 54.2% in terms of value. As described in a research report released
5th Global Respiratory and Pulmonologist Annual Meeting
Pulmonology » | Pulmonology Conference » | Respiratory Congress » | Pulmonologists Meeting » | COPD Conference » On behalf of the Conference Organizing Committee, it is with great pleasure that we welcome you to the official website of 5th Global Respiratory and Pulmonologist Annual Meeting during November 17-18, 2016 at Dubai, UAE. Conference Theme: Optimizing Research strategies & Neoteric developments in Pulmonary Disorders Respiratory disorders is a medical terminology which includes
Respiratory Distress in Premature Infants
FOR IMMEDIATE RELEASE New York, NY:Respiratory distress syndrome (RDS) is a breathing condition common in premature infants whose lungs have not fully developed yet. The earlier the birth in gestational time, the more prone the infant is to RDS and the more severe it is likely to be. Fully developed lungs are coated with a naturally occurring slippery substance called surfactant. Surfactant lines the air sacs in the lungs and reduces surface